Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, India

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Singla, Neeta ^a   Satyanarayana, Srinath ^b   Sachdeva, Kuldeep Singh ^c   Van Den Bergh, Rafael ^d   Reid, Tony ^d   Tayler Smith, Katherine ^d   Myneedu, V P ^a   Ali, Engy ^d   Enarson, Donald A ^b   Behera, Digamber ^e   Sarin, Rohit ^a  

^a National Institute of TB and Respiratory Diseases (NITRD)   (India)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c GOVERNMENT OF INDIA   (India)

^d MÉDECINS SANS FRONTIÈRES   (Belgium)

^e POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; KANAMYCIN; LEVOFLOXACIN; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INDIA; LINE PROBE ASSAY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PATIENT CARE; RETROSPECTIVE STUDY; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT INDICATION; BIOASSAY; DRUG EFFECTS; FOLLOW UP; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

ADULT; ANTITUBERCULAR AGENTS; BIOLOGICAL ASSAY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INDIA; LOST TO FOLLOW-UP; MALE; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; TIME-TO-TREATMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84904880495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102989     Document Type: Article

References (15)

1. World Health Organization, Geneva (2008) Guidelines for the programmatic management of drug-resistant tuberculosis; An emergency update. (WHO/HTM/TB/2008/402).
2. Schaaf HS, Shean K, Donald PR (2003) Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child 88: 1106-1111. (Pubitemid 38064490)
3. Narasimooloo R, Ross A (2012) Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal. S Afr Med J 102: 360-362.
4. Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, et al. (2009) Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis 13: 976-981.
5. Central TB Division (2010) DOTS Plus Guidelines, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India.
6. Central TB Division (2012) Guidelines on Programmatic Management of Drug Resistant TB (PMDT), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India.
7. World Health Organization. (2011) Global tuberculosis control: WHO report 2011. Geneva: World Health Organization. viii, 246 p.
8. Central TB Division, TB India (2012) Directorate General of Helath Services, Ministry of health and Family Welfare, Govt of India.
9. Hoek KG, Van Rie A, van Helden PD, Warren RM, Victor TC (2011) Detecting drug-resistant tuberculosis: the importance of rapid testing. Mol Diagn Ther 15: 189-194.
10. World Health Organization, (2010) Multidrug and Extensively Drug-resistant TB: Global Report on Surveillance and Response. Available: http://whqlibdoc.who.int/publications/2010/9789241599191-eng.pdf. Accessed 2013 July 12.
11. Singhal R, Arora J, Lal P, Bhalla M, Myneeedu VP, et al. (2012) Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis. Indian J Med Res 136: 1044-1047.
12. World Health Organization, (2008) Molecular Line Probe Assays for Rapid Screening of Patients at Risk ofMultidrug-resistant Tuberculosis. A Policy Statement. Available: http://www.who.int/tb/laboratory/lpa-policy.pdf. Accessed 2013 July 12.
13. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, et al. (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41: 21-43.
14. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M (2006) Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 44: 4459-4463. (Pubitemid 44940754)
15. Chadha SS, Sharath BN, Reddy K, Jaju J, Vishnu PH, et al. (2011) Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLoS One 6: e26659.